AIM ImmunoTech Inc (AIM) concluded trading on Wednesday at a closing price of $0.14, with 5.11 million shares of worth about $0.72 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -63.26% during that period and on Wednesday the price saw a gain of about 9.60%. Currently the company’s common shares owned by public are about 68.75M shares, out of which, 60.91M shares are available for trading.
Stock saw a price change of 1.42% in past 5 days and over the past one month there was a price change of -35.05%. Year-to-date (YTD), AIM shares are showing a performance of -31.41% which decreased to -67.48% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.11 but also hit the highest price of $0.62 during that period. The average intraday trading volume for AIM ImmunoTech Inc shares is 926.80K. The stock is currently trading -11.41% below its 20-day simple moving average (SMA20), while that difference is down -27.39% for SMA50 and it goes to -52.20% lower than SMA200.
AIM ImmunoTech Inc (AMEX: AIM) currently have 68.75M outstanding shares and institutions hold larger chunk of about 6.76% of that.
The stock has a current market capitalization of $9.34M and its 3Y-monthly beta is at 0.42. It has posted earnings per share of -$0.47 in the same period. It has Quick Ratio of 0.75 while making debt-to-equity ratio of 1.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AIM, volatility over the week remained 17.86% while standing at 14.12% over the month.
Stock’s fiscal year EPS is expected to rise by 50.00% while it is estimated to decrease by -16.67% in next year.
